Company / Book Value per Share
Acadia Pharmaceuticals Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$7.362
FY2025
5-year range
$2.487 / $7.362
FY2021-FY2025
Trend
+65.4%
vs FY2024
Sector context
#79 of 209
Health Care
What the data says
At $7.362, Acadia Pharmaceuticals's book value per share ranks #79 of 209 in the Health Care sector. Book Value per Share has increased for 3 consecutive years, from $2.487 in FY2022 to $7.362 in FY2025.
Based on SEC 10-K filings.
$7.362 in FY2025 with a 5-year CAGR of +12.8%.
Improved from $2.664 to $7.362 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +43.6%
- 5-Year CAGR
- +12.8%
- 10-Year CAGR
- -
Sector benchmark
#79 of 209 in Health CareTop 38% of 209This company $7.362 Sector average $215.686
▼
-96.6% below sector average
Key checks
Key Insights
- Acadia Pharmaceuticals's book value per share has grown for 3 consecutive years.
- 5-year CAGR of +12.8%, indicating consistent growth.
- In FY2025, book value per share increased 65.4% year-over-year.
- Ranks #79 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 24.9%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 28.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.362 | +65.4% |
| FY2024 | $4.451 | +67.1% |
| FY2023 | $2.664 | +7.1% |
| FY2022 | $2.487 | -26.6% |
| FY2021 | $3.388 | -16.1% |
| FY2020 | $4.038 | -16.9% |
| FY2019 | $4.86 | +26.2% |
| FY2018 | $3.851 | +39.4% |
| FY2017 | $2.763 | -45.7% |
| FY2016 | $5.086 | +154.7% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026